Evamyl


Indications and Reactions:

Role Indications Reactions
Secondary
Depression 42.5%
Product Used For Unknown Indication 18.3%
Insomnia 7.8%
Drug Use For Unknown Indication 5.5%
Schizophrenia 5.0%
Rosacea 2.7%
Urinary Tract Infection 2.7%
Anxiety 2.3%
Gastric Ulcer 1.8%
Antidepressant Therapy 1.4%
Ascites 1.4%
Lung Neoplasm Malignant 1.4%
Dehydration 0.9%
Headache 0.9%
Hepatitis 0.9%
Herpes Simplex Hepatitis 0.9%
Hypothyroidism 0.9%
Irritability 0.9%
Mycobacterium Avium Complex Infection 0.9%
Nasopharyngitis 0.9%
Renal Failure Acute 16.2%
Toxic Epidermal Necrolysis 13.5%
Rash 8.1%
Stevens-johnson Syndrome 8.1%
Suicide Attempt 8.1%
Therapeutic Agent Toxicity 8.1%
Hydronephrosis 5.4%
Liver Disorder 5.4%
Pleural Effusion 5.4%
Drug Interaction 2.7%
Gastrointestinal Haemorrhage 2.7%
Headache 2.7%
Mania 2.7%
Reflux Oesophagitis 2.7%
Tinea Infection 2.7%
Urinary Retention 2.7%
Vaginitis Gardnerella 2.7%
Concomitant
Insomnia 14.5%
Depression 13.3%
Prophylaxis 12.3%
Schizophrenia 9.3%
Anxiety 5.9%
Chronic Hepatitis C 5.0%
Hepatitis C 5.0%
Aplastic Anaemia 4.9%
Constipation 4.6%
Hypertension 4.3%
Product Used For Unknown Indication 3.2%
Cardiac Failure Congestive 2.8%
Rheumatoid Arthritis 2.6%
Sleep Disorder 2.4%
Drug Use For Unknown Indication 2.1%
Hiv Infection 1.9%
Diabetes Mellitus 1.5%
Gastric Ulcer 1.4%
Hallucination 1.4%
Irritability 1.4%
Pancytopenia 13.0%
Rash 8.7%
White Blood Cell Count Decreased 7.8%
Suicide Attempt 6.1%
Pulmonary Embolism 5.2%
Pyrexia 5.2%
Anaemia 4.3%
Completed Suicide 4.3%
Decreased Appetite 4.3%
Nausea 4.3%
Vomiting 4.3%
White Blood Cell Count Increased 4.3%
Diabetes Mellitus 3.5%
Haemorrhage 3.5%
Hepatic Function Abnormal 3.5%
Insomnia 3.5%
Overdose 3.5%
Palmar-plantar Erythrodysaesthesia Syndrome 3.5%
Platelet Count Decreased 3.5%
Self Injurious Behaviour 3.5%

Drug Data